Status:
COMPLETED
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Denys-Drash Syndrome
Frasier Syndrome
Eligibility:
All Genders
Brief Summary
The Wilms' tumor suppressor gene 1 (WT1) encodes for a transcription factor which plays an important role during urogenital development. Patients carrying a WT1 germline mutation show symptoms like pr...
Detailed Description
The Wilms' tumor suppressor gene 1 (WT1) encodes for a transcription factor which plays an important role during urogenital development. Patients carrying a WT1 germline mutation show symptoms like pr...
Eligibility Criteria
Inclusion
- Germline mutation in WT1 gene
Exclusion
- none
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01252901
Start Date
October 1 2010
End Date
June 1 2014
Last Update
May 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätskrankenhaus Hamburg-Eppendorf
Hamburg, Germany